Dyadic Logo Current.jpg
Dyadic to Attend Industry Events in June
30 mai 2024 16h30 HE | Dyadic International, Inc.
JUPITER, Fla., May 30, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a biotechnology company focused on the efficient large-scale manufacture of...
Global Plant-based Meat Markets
Global Plant-based Meat Global Market Report 2024-2028 Featuring Art of Greens, Beyond Meat, Biolab, Conagra Brands, Impossible Foods, Maple Leaf Foods, Monde Nissin, Tofurky, Tyson Foods, & Vbites
28 mai 2024 05h33 HE | Research and Markets
Dublin, May 28, 2024 (GLOBE NEWSWIRE) -- The "Plant-based Meat: Global Markets 2023-2028" report has been added to ResearchAndMarkets.com's offering. The global market for plant-based meat is...
Dyadic Logo Current.jpg
Dyadic Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress
14 mai 2024 16h00 HE | Dyadic International, Inc.
Human Health Sector Final Clinical Study Report has been issued for the First-In-Human Phase 1 clinical trial demonstrating safety and antibody response for DYAI-100, a recombinant...
Dyadic Logo Current.jpg
Dyadic to Attend Industry and Investor Events in May
08 mai 2024 08h30 HE | Dyadic International, Inc.
JUPITER, Fla., May 08, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial...
Dyadic Logo Current.jpg
Dyadic to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024
30 avr. 2024 16h30 HE | Dyadic International, Inc.
JUPITER, Fla., April 30, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a biotechnology company focused on the efficient...
Dyadic Logo Current.jpg
Dyadic Reports 2023 Full Year Results and Recent Company Progress
28 mars 2024 16h00 HE | Dyadic International, Inc.
Closed a $6.0 million convertible note in a private placement, with a conversion price of $1.79 and no warrantsReported positive topline data from First-In-Human Phase 1 trial demonstrated clinical...
Dyadic Logo Current.jpg
Dyadic Announces Change in Board and Management Leadership Roles
28 mars 2024 08h30 HE | Dyadic International, Inc.
JUPITER, Fla., March 28, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a biotechnology company focused on the efficient...
Dyadic Logo Current.jpg
Dyadic to Attend Industry Events in April
27 mars 2024 08h30 HE | Dyadic International, Inc.
JUPITER, Fla., March 27, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial...
Dyadic Logo Current.jpg
Dyadic to Attend Future Food Tech Event March 21 – 22, 2024 in San Francisco, California
21 mars 2024 08h30 HE | Dyadic International, Inc.
JUPITER, Fla., March 21, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial...
Dyadic Logo Current.jpg
Dyadic to Report Full Year 2023 Financial Results and Host Conference call on Thursday, March 28, 2024
14 mars 2024 16h30 HE | Dyadic International, Inc.
JUPITER, Fla., March 14, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused building...